BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 46 filers reported holding BURNING ROCK BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,245,000 | -55.0% | 8,500,000 | 0.0% | 1.35% | -46.4% |
| Q2 2023 | $18,309,473 | -18.8% | 8,500,000 | +6.0% | 2.52% | -13.4% |
| Q1 2023 | $22,537,956 | +35.5% | 8,020,625 | +8.5% | 2.91% | +14.0% |
| Q4 2022 | $16,631,057 | +3.8% | 7,391,581 | +10.3% | 2.55% | -24.4% |
| Q3 2022 | $16,022,000 | +28.0% | 6,703,863 | +55.9% | 3.38% | +5.6% |
| Q2 2022 | $12,513,000 | +74.2% | 4,300,000 | +456.2% | 3.20% | +37.2% |
| Q1 2022 | $7,182,000 | +97.0% | 773,114 | +102.1% | 2.33% | +19.6% |
| Q4 2021 | $3,645,000 | – | 382,464 | – | 1.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |